Authors:
Gunasekera, RD
Notghi, A
Mostafa, AB
Harding, LK
Citation: Rd. Gunasekera et al., Adsorption of radiopharmaceuticals to syringes leads to lower administeredactivity than intended, NUCL MED C, 22(5), 2001, pp. 493-497
Authors:
Abram, WP
Buxton-Thomas, M
Carty, HML
Clarke, SEM
Coakley, AJ
Cunningham, D
Ell, P
Elliott, AT
Frier, M
Gordon, I
Gibson, CJ
Gillen, GJ
Harding, LK
Henk, JM
Hesslewood, SR
Kendall, GM
Lewington, V
McCready, VR
Mather, SJ
McKillop, JH
Millar, A
Mountford, P
Nunan, T
Palmer, M
Pippard, M
Prescott, MC
Shields, RA
Stather, JW
Stocks, MA
Thomas, WH
Tindale, W
Waller, DG
Watkinson, JC
Citation: Wp. Abram et al., Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources, NUCL MED C, 21, 2000, pp. III
Citation: Ra. Shields et Lk. Harding, Comments on the British Institute of Radiology Working Party advice for patients after radionuclide therapy - Authors' reply, BR J RADIOL, 73(868), 2000, pp. 454-454
Authors:
Barrington, SF
O'Doherty, MJ
Kettle, AG
Thomson, WH
Mountford, PJ
Burrell, DN
Farrell, RJ
Batchelor, S
Seed, P
Harding, LK
Citation: Sf. Barrington et al., Radiation exposure of the families of outpatients treated with radioiodine(iodine-131) for hyperthyroidism, EUR J NUCL, 26(7), 1999, pp. 686-692
Authors:
Pauwels, EKJ
Thomson, WH
Blokland, JAK
Schmidt, ME
Bourguignon, M
El-Maghraby, TAF
Broerse, JJ
Harding, LK
Citation: Ekj. Pauwels et al., Aspects of fetal thyroid dose following iodine-131 administration during early stages of pregnancy in patients suffering from benign thyroid disorders, EUR J NUCL, 26(11), 1999, pp. 1453-1457
Authors:
Barrington, SF
O'Doherty, MJ
Kettle, AG
Thomson, WH
Mountford, PJ
Burrell, DN
Farrell, RJ
Batchelor, S
Seed, P
Harding, LK
Citation: Sf. Barrington et al., Radiation exposure of the families of outpatients treated with radioiodine(iodine-131) for hyperthyroidism (vol 26, pg 686, 1999), EUR J NUCL, 26(10), 1999, pp. 1382-1382